Trial intelligence / Profile preview

Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy

NCT05868122Phase 3Completed

Sponsor
Johnson & Johnson
Start
Sep 2023
Primary completion
May 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in acute postoperative pain comparing Acetaminophen/Naproxen Sodium Fixed Combination with Placebo (2 arms). Primary endpoint: Time-weighted Sum of Pain Intensity Difference at 24 hours. Started Sep 2023; status: completed.

02

Drugs

acetaminophenAprol
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on NCT05868122.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05868122.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call